Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1047644-62-1
2. Gsk-2110183
3. Gsk2110183c
4. Afuresertib [usan]
5. Asb183
6. Asb-183
7. Gsk 2110183c
8. Afuresertib (gsk2110183)
9. Afuresertib (usan)
10. 8739x25qi3
11. Gsk-2110183c
12. N-[(2s)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)thiophene-2-carboxamide
13. 2-thiophenecarboxamide, N-((1s)-2-amino-1-((3-fluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-
14. N-((1s)-1-(aminomethyl)-2-(3-fluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)thiophene-2-carboxamide
15. Afuresertib [usan:inn]
16. Unii-8739x25qi3
17. 2-thiophenecarboxamide, N-[(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-
18. N-((2s)-1-amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)thiophene-2-carboxamide
19. N-[(2s)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)thiophene-2-carboxamide
20. Afuresertib [inn]
21. Afuresertib [who-dd]
22. Schembl187686
23. Gtpl7890
24. Chembl2219422
25. Dtxsid60146711
26. Chebi:131168
27. Bcp08435
28. Ex-a1574
29. Bdbm50502477
30. Nsc778305
31. Nsc781255
32. Nsc800109
33. Nsc829868
34. S7521
35. Zinc43197674
36. Ccg-268972
37. Cs-3384
38. Db11648
39. Nsc-778305
40. Nsc-781255
41. Nsc-800109
42. Nsc-829868
43. Gsk 2110183
44. Ncgc00387879-03
45. Ac-35761
46. Ba166066
47. Bs-14212
48. Hy-15727
49. A16392
50. D10381
51. D71036
52. A853608
53. Afuresertib, Gsk-2110183, Gsk-2110183b
54. Q27224945
55. N-((s)-1-amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)thiophene-2-carboxamide
56. N-((s)-1-amino-3-(3-fluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)thiophene-2-carboxamide;afuresertib
57. N-[(2s)-1-amino-3-(3-fluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methyl-3-pyrazolyl)-2-thiophenecarboxamide
58. N-{(1s)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1h-pyrazol-5-yl)-2-thiophenecarboxamide
| Molecular Weight | 427.3 g/mol |
|---|---|
| Molecular Formula | C18H17Cl2FN4OS |
| XLogP3 | 4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 426.0484159 g/mol |
| Monoisotopic Mass | 426.0484159 g/mol |
| Topological Polar Surface Area | 101 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 520 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
15
PharmaCompass offers a list of Afuresertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Afuresertib manufacturer or Afuresertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Afuresertib manufacturer or Afuresertib supplier.
PharmaCompass also assists you with knowing the Afuresertib API Price utilized in the formulation of products. Afuresertib API Price is not always fixed or binding as the Afuresertib Price is obtained through a variety of data sources. The Afuresertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Afuresertib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Afuresertib, including repackagers and relabelers. The FDA regulates Afuresertib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Afuresertib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Afuresertib supplier is an individual or a company that provides Afuresertib active pharmaceutical ingredient (API) or Afuresertib finished formulations upon request. The Afuresertib suppliers may include Afuresertib API manufacturers, exporters, distributors and traders.
Afuresertib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Afuresertib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Afuresertib GMP manufacturer or Afuresertib GMP API supplier for your needs.
A Afuresertib CoA (Certificate of Analysis) is a formal document that attests to Afuresertib's compliance with Afuresertib specifications and serves as a tool for batch-level quality control.
Afuresertib CoA mostly includes findings from lab analyses of a specific batch. For each Afuresertib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Afuresertib may be tested according to a variety of international standards, such as European Pharmacopoeia (Afuresertib EP), Afuresertib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Afuresertib USP).
